TAG:
managed care companies
Bio-Reference Labs, CARESIDE, United Healthcare, MetLife, Foundation Health
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
BIO-REFERENCE LABS MOVES TO START PATIENT-DOCTOR MESSAGING ONE OF THE NATION’S MORE AGGRESSIVE efforts to refocus the clinical laboratory organization can be found at Bio-Reference Laboratories, Inc., located in Elmwood Park, New Jersey. Bio-Reference wants to use its bas…
“January 24, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
Financial progress at Tenet Health Corp. provides a glimpse at how the hospital industry is faring. Tenet announced a 7.2% increase in revenues for fiscal second quarter, fueled primarily by an increase in patient admissions at its 113 hospitals. Tenet also reported an average increa…
LabCorp and CIGNA Ink New Provider Agreement
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
CEO SUMMARY: After four years of working with SmithKline Beecham Clinical Labs as its sole designated laboratory provider, Cigna Healthcare recently opened the door to Laboratory Corporation of America. THE DARK REPORT believes this development is first evidence that the nation’s larges…
Specialty Labs Moving To Web-Based Services
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
CEO SUMMARY: Competition for hospital reference and esoteric testing remains intense. Three years ago, Specialty Laboratories made an early bet on Internet technology. It believed that being first to offer faster and less complicated access to laboratory informatics resources would give i…
California’s Physicians Face Financial Meltdown
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: It’s a what-if scenario that may come true. Healthcare providers in the Golden State are going broke at an astounding rate. Physicians seem to be the hardest hit, but signs indicate that hospitals are also heading toward serious financial difficulties. In a nutshell, a deca…
Finally: Respect for Cytyc As Aetna OKs ThinPrep®
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: Here’s an important development in the battle to get the healthcare community to accept new technology for the preparation of Pap smears. Aetna/U.S. Healthcare announced that it would cover the monolayer preparation tests offered by Cytyc and AutoCyte. Aetna’s decision ma…
KC Regional Lab Network Makes Steady Progress
By Robert Michel | From the Volume VI No. 12 – August 30, 1999 Issue
CEO SUMMARY: In Kansas City, members of the Regional Laboratory Alliance (RLA) had a common purpose in forming their network four years ago—to preserve their status as laboratory provider for a major managed care plan in their area. After successfully attaining that goal, RLA’s member…
Quest Diagnostics and LabCorp Face an Evolving Marketplace
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
TWO OF THE THREE BLOOD BROTHERS reported continued improvement in their financial condition as second quarter earnings reports were made public. This news, however, was overshadowed by speculation about the failure of Quest Diagnostics Incorporated to consummate its purchase of …
DIANON Systems Nails Contract To Provide AP Services To Aetna
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
Sand sales efforts paid off for DIANON Systems, Inc. of Stratford, Connecticut. Last month the publicly-traded lab disclosed a new contract with Aetna/U.S. Healthcare. The pact, signed with Aetna and SmithKline Beecham Clinical Laboratories (SBCL), …
A Tale of Two Cities: New York Versus L.A.
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
CEO SUMMARY: Here’s a dramatic comparison of the effects of advanced managed care on West Coast laboratories as compared to East Coast laboratories. While Los Angeles labs endured radical downsizing and bankruptcy, New York experienced significant increases to existing laboratory capaci…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized